The Metabolic Equivalent BMI in Patients with Familial Partial Lipodystrophy (FPLD) Compared with Those with Severe Obesity is a research paper published in Obesity (2021). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Foundation for the National Institutes of Health
Grant: DK034933
Foundation for the National Institutes of Health
Grant: DK088114
NIDDK NIH HHS
Grant: R21 DK098776
NIDDK NIH HHS
Grant: P30 DK034933
NIDDK NIH HHS
Grant: P30 DK089503
NCATS NIH HHS
Grant: UL1 TR000433
NIDDK NIH HHS
Grant: R01 DK088114
FWCI
0.96
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study
Additional file 1 of Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study